STERIS plc (STE)
NYSE · Healthcare · Medical Devices
$211.07+1.21%as of Oct 6, 2026, 7:35 AM ET
- Market cap
- $20.6B
- P/E (trailing)
- 25.8
- Forward P/E
- 17.2
- Dividend yield
- 1.2%
- 52-week range
- $195.14 – $269.44
- 52-week change
- −13.67%
- EPS (trailing)
- $8.18
- Analyst rating
- 1.8 Buy
- Next earnings
- Nov 4, 2026
Fiscal year to Mar 2026
- Revenue
- $5.9B (+8.73%)
- Net income
- $782M
- Operating margin
- 18.6%
- Diluted EPS
- $7.93
- Free cash flow
- $972M
From the company’s annual report on SEC EDGAR.
About STERIS plc
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services.
Headquarters: Mentor, United States · 17,937 employees · steris.com